Skip to Main Content

Print | Bookmark | Email | Font Size: + |

August 22, 2023

Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers: For Clinicians

Join the CGS J15 Part A and B Chief Medical Officer, Meredith Loveless, MD. FACOG on Thursday, September 21, 2023 from 4:00PM to 5:00PM Eastern Time, to discuss the CGS Local Coverage Determination (LCD) L36690 Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers and A56696 Billing and Coding: Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers.  During this call you will be able to review the recent policy guidelines that were implemented on August 3, 2023 for LCD L36690/A56696.

This event is being scheduled after hours to accommodate clinicians schedule.

Registration is required at: https://events.teams.microsoft.com/event/e1843071-518c-4b09-a989-d33775e0d9ab@d560165e-85d7-436f-a978-c588cf12ebe1External Website

Once you register to attend this event you will see the items that will be discussed during this hour event.  We ask that you take a few minutes review and submit your questions prior to the event.

Pre-submitted questions can be submitted to J15_PARTB_EDUCATION@cgsadmin.com

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved